Files in This Item:


Title: Epidemiological and cost analysis of multidrug-resistant tuberculosis in Oman
Authors: Mohammadi, A.
Nassor, Z.S.
Behlim, T.
Mohammadi, E.
Govindarajan, R.
Al Maniri, A.
Smego, Jr R.A.
Issue Date: 2008
Language: English
Abstract: We conducted an epidemiological and cost analysis for all 13 patients diagnosed with multaidrug-resistant tuberculosis [11 pulmonary, 2 extrapulmonary] in Oman from January 2000 to October 2005. The disease was secondary, or acquired, in 12 of 13 patients. A total of 140 contacts were screened [mean 10.8 persons per patient], but contact tracing revealed no secondary cases. The mean number of drugs that TB isolates were resistant to was 2.8 [range 2-5]. A mean of 4.7 drugs were given to patients, the mean length of therapy was 8 months and all patients were cured. The cost of medications for these multidrug-resistant cases was 14 to 29 times higher than that for the standard drug-sensitive TB regimen
Description: 1240-1245
Keywords: Tuberculosis, Multidrug-Resistant
Costs and Cost Analysis
Retrospective Studies
Risk Factors
Early Diagnosis
Subject: Tuberculosis, Multidrug-Resistant
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.